Dr Harold Gunson informed RTC directors that screening for anti-HCV would begin on 1 July 1991. Read more about Dr Harold Gunson informed RTC directors that screening for anti-HCV would begin on 1 July 1991.
Minister approved routine screening for Hepatitis C. Read more about Minister approved routine screening for Hepatitis C.
The ACVSB agreed Hepatitis C screening should be started as soon as practicable but no date was proposed. Read more about The ACVSB agreed Hepatitis C screening should be started as soon as practicable but no date was proposed.
The ACVSB approved Hepatitis C screening in principle but recommended there should be a pilot study to decide which test (Ortho or Abbott) was better. Read more about The ACVSB approved Hepatitis C screening in principle but recommended there should be a pilot study to decide which test (Ortho or Abbott) was better.
The FDA approved the anti-HCV ELISA test and US blood banks commenced screening. Read more about The FDA approved the anti-HCV ELISA test and US blood banks commenced screening.
The ACVSB decided the introduction of routine Hepatitis C screening was not yet justified. Read more about The ACVSB decided the introduction of routine Hepatitis C screening was not yet justified.
The ACVSB decided that Hepatitis C testing should not be introduced in advance of a decision by the FDA. Read more about The ACVSB decided that Hepatitis C testing should not be introduced in advance of a decision by the FDA.
The FDA granted a permit for the Chiron/Ortho test (Hepatitis C test) to be exported for diagnostic use as well as research. Read more about The FDA granted a permit for the Chiron/Ortho test (Hepatitis C test) to be exported for diagnostic use as well as research.
It was agreed at a meeting of the ACVSB to support the general introduction of the test for Hepatitis C if the FDA approved it and the pilot showed it to be "feasible and non-problematic". Read more about It was agreed at a meeting of the ACVSB to support the general introduction of the test for Hepatitis C if the FDA approved it and the pilot showed it to be "feasible and non-problematic".
By this date it was agreed that a decision whether and when to implement a screening test for Hepatitis C would be made on a UK-wide basis. Read more about By this date it was agreed that a decision whether and when to implement a screening test for Hepatitis C would be made on a UK-wide basis.